Xeris Biopharma Holdings Inc (XERS)
EBITDA Margin
4.95%
TTM · Period ending:
XERS EBITDA Margin
Latest reported4.95%period ending
Latest reported4.95%period ending
XERS TTM EBITDA Margin (-1695.89% → 4.95%)
TTM ebitda margin
High-resolution chart · PNG
XERS ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 4.9458% | |
| 14.6503% | |
| 12.0019% | |
| 10.0035% | |
| 3.005% | |
| -1.9497% | |
| -6.8912% | |
| -12.311% | |
| -9.5015% | |
| -14.429% | |
| -14.4802% | |
| -16.8889% | |
| -28.7687% | |
| -39.5144% | |
| -61.7617% | |
| -112.1643% | |
| -149.3026% | |
| -196.2093% | |
| -228.2221% | |
| -233.3494% | |
| -212.9% | |
| -253.4871% | |
| -387.1935% | |
| -620.9559% | |
| -1,826.6078% | |
| -2,819.1385% | |
| -4,275.7532% | |
| -6,226.8322% | |
| -4,633.1625% | |
| -2,842.5306% | |
| -2,321.0953% | |
| -2,210.9808% | |
| -2,362.4782% | |
| -2,281.9113% | |
| -1,695.8869% |